368 related articles for article (PubMed ID: 17168451)
21. Thrombosis in childhood cancer.
Allen GA; Bhat R
Cancer Treat Res; 2009; 148():223-42. PubMed ID: 19377927
[No Abstract] [Full Text] [Related]
22. Quick reference guide to the new oral anticoagulants.
Hurst K; Lee R; Handa A
J Vasc Surg; 2016 Jun; 63(6):1653-7. PubMed ID: 27113315
[TBL] [Abstract][Full Text] [Related]
23. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
24. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
[TBL] [Abstract][Full Text] [Related]
25. Thrombosis and cancer.
Kakkar AK
Hematol J; 2004; 5 Suppl 3():S20-3. PubMed ID: 15190272
[TBL] [Abstract][Full Text] [Related]
26. Heparin and low-molecular-weight heparin.
Gray E; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
[TBL] [Abstract][Full Text] [Related]
27. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.
Sutherland DE; Weitz IC; Liebman HA
Am J Hematol; 2003 Jan; 72(1):43-52. PubMed ID: 12508268
[TBL] [Abstract][Full Text] [Related]
28. Rethinking the approach to thrombosis in patients with cancer.
Khorana AA
Vasc Med; 2020 Jun; 25(3):208-209. PubMed ID: 31718489
[No Abstract] [Full Text] [Related]
29. Venous thromboembolism in oncology.
Falanga A; Vignoli A
Eksp Onkol; 2004 Mar; 26(1):11-4. PubMed ID: 15112573
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive pharmacologic therapy in percutaneous coronary intervention: part II anticoagulant therapy.
Kim SJ; Giugliano RP; Jang IK
Coron Artery Dis; 2011 Mar; 22(1):113-21. PubMed ID: 21304293
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic treatment in atrial fibrillation.
Kalra L; Lip GY;
Heart; 2007 Jan; 93(1):39-44. PubMed ID: 16952971
[No Abstract] [Full Text] [Related]
32. [Summary and perspectives. Rivaroxaban].
Albaladejo P
Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S28-31. PubMed ID: 19185785
[TBL] [Abstract][Full Text] [Related]
33. Factor XI as a Therapeutic Target.
Gailani D; Gruber A
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1316-22. PubMed ID: 27174099
[TBL] [Abstract][Full Text] [Related]
34. Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
[TBL] [Abstract][Full Text] [Related]
35. [Controversies in oncology. Venous thromboembolism and cancer: what is done and what should be done. Milan, May 18, 2002].
Tumori; 2002; 88(4):A8-17. PubMed ID: 12402833
[No Abstract] [Full Text] [Related]
36. Enoxaparin for the prevention of venous thromboembolism.
Calderon EJ; Varela JM; Gonzalez de la Puente MA
N Engl J Med; 2000 Jan; 342(2):136-7. PubMed ID: 10636758
[No Abstract] [Full Text] [Related]
37. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
38. Antithrombotic therapy for the CardioWest temporary total artificial heart.
Ensor CR; Cahoon WD; Crouch MA; Katlaps GJ; Hess ML; Cooke RH; Gunnerson KJ; Kasirajan V
Tex Heart Inst J; 2010; 37(2):149-58. PubMed ID: 20401285
[TBL] [Abstract][Full Text] [Related]
39. Overview of cancer and thrombosis.
Matzdorff AC; Green D
Cancer Treat Res; 2009; 148():83-94. PubMed ID: 19377920
[No Abstract] [Full Text] [Related]
40. Venous thromboembolism and cancer.
Kakkar AK; de Lorenzo F; Pineo GF; Williamson RC
Baillieres Clin Haematol; 1998 Sep; 11(3):675-87. PubMed ID: 10331099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
